These two studies provide evidence that, at least in ovarian and breast cancer, ABCB1 gene fusions that retain exon 2 onwards lead to the upregulation of P-gp and are responsible for acquired chemotherapy resistance. The gene discussed is ABCB1; the disease is breast cancer.